Five-year relative survival rates for all cancers combined have increased to 70% for people diagnosed during 2015 to 2021 in ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Women with pulmonary hypertension have a lower risk of death than men, suggesting sex should be considered as a risk factor, ...

Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...

Of the Arkansas businesses that started up in 2019, almost half of them, 49.4%, were still operating through 2024, according to data from the U.S. Bureau of Labor Statistics. There were 6,097 new ...

Global rates of hypertension, or high blood pressure, in childhood and adolescence have nearly doubled since 2000, putting more kids at risk for poor health later in life. “In 2000, about 3.4% of boys ...

Background: Presently pediatric pulmonary hypertension (PH) lacks a widely accepted risk assessment algorithm and clear guidelines for treatment. Most targeted therapies are used off-label in ...

A common vaccine could help to fight cancer, a new study suggests. For cancer patients undergoing immunotherapy, researchers found that receiving the mRNA COVID-19 vaccine within about 100 days of ...